Skip to main content

Table 16 cross validation results

From: Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of alzheimer's disease

  

Predicted

  

NC

AD

Original

NC

93.3%

6.7%

 

AD

16.7%

83.3%

  1. 88.3% of cross-validated cases correctly classified